No Prescription |
 |
 | ||
|
A Ret Gel Retin A |
|
| ||
No Prescription » Prescription Drugs 1 » A Ret Gel Retin A This medication is used to treat acne. It may decrease the number and severity of acne pimples and promote quick healing of pimples that do develop. Tretinoin belongs to a class of medications called retinoids. It works by affecting the growth of skin cells.How to use Tretinoin TopRead the Patient Information Leaflet if one is available from your pharmacist. Consult your doctor or pharmacist if you have questions.Wash your hands before applying this medication. Gently clean the affected skin with a mild or soapless cleanser and pat dry. Use your fingertips to apply a small amount of medication (about the size of a pea) in a thin layer usually once daily at bedtime or as directed by your doctor. A gauze pad or cotton swab can be used to apply the liquid. For some preparations you should wait 20-30 minutes after cleaning your face before applying this medication. Consult the label directions the Patient Information Leaflet or your pharmacist if you have any questions.Use this medication on the skin only. Do not apply to the inner lip area or inside the nose/mouth. Do not apply to cut scraped sunburned or eczema-affected skin.Avoid getting this medication in your eyes. If this medication gets into your eyes flush with large amounts of water. Call your doctor if eye irritation develops. Wash your hands after using the medication to avoid accidentally getting it in your eyes.During the first few weeks of using tretinoin your acne might appear worse because the medication is working on pimples forming inside the skin. It may take up to 8-12 weeks to notice results from this medication.Use it regularly in order to get the most benefit from it. To help you remember use it at the same time each day. Do not use a larger amount or use it more frequently than recommended. Your skin will not improve any faster and it will increase the risk of developing redness peeling and pain.This medication is available in different strengths and forms (e.g. gel cream solution). The best type of medication for you to use will depend on the condition of your skin and your response to therapy. Inform your doctor if your condition persists or worsens. Buy A Ret Gel Retin A and other Prescription Drugs 1 products online at Medstore. Buy Online at Medstore - Click Here!
About A Ret Gel Retin A: Product Type: Prescription Drugs 1 A-Ret Gel ( Retin-A Generic Tretinoin ) A-Ret Gel (Retin-A Generic Tretinoin) Retin-A Generic Tretinoin 0.025%w/v 20gm 0.025%w/v 3 x 20gm 0.025%w/v 6 x 20gm 0.05%w/w 60gm(3 x 20gm) 0.05%w/w 20gm 0.05%w/w 120gm(6 x 20gm) Retin-A Generic Tretinoin A-Ret Gel
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
